Web Stats Provided By Google Analytics

Thursday, March 27, 2014

Keryx CEO Says U.S. House Bill Would Be Boost on Dialysis Drugs

Keryx Biopharmaceuticals Inc. said it expected to benefit from proposed U.S. legislation that would continue a pricing system for dialysis drugs, sending its shares up the most in almost five months.

http://ift.tt/1jNkMLC

No comments:

Post a Comment

Popular Healthcare Law Roundup Posts